144 related articles for article (PubMed ID: 9007083)
1. Repression of p53 transcriptional activity by the HPV E7 proteins.
Massimi P; Banks L
Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
[TBL] [Abstract][Full Text] [Related]
2. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
Massimi P; Pim D; Storey A; Banks L
Oncogene; 1996 Jun; 12(11):2325-30. PubMed ID: 8649772
[TBL] [Abstract][Full Text] [Related]
3. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.
Maldonado E; Cabrejos ME; Banks L; Allende JE
J Cell Biochem; 2002; 85(4):663-9. PubMed ID: 11968006
[TBL] [Abstract][Full Text] [Related]
6. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
Hermonat PL; Santin AD; Zhan D
J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
Avvakumov N; Torchia J; Mymryk JS
Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
Pim D; Storey A; Thomas M; Massimi P; Banks L
Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
[TBL] [Abstract][Full Text] [Related]
10. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes.
Liu X; Han S; Baluda MA; Park NH
Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
12. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
Murvai M; Borbély AA; Kónya J; Gergely L; Veress G
Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353
[TBL] [Abstract][Full Text] [Related]
13. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
14. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis.
Stöppler H; Stöppler MC; Johnson E; Simbulan-Rosenthal CM; Smulson ME; Iyer S; Rosenthal DS; Schlegel R
Oncogene; 1998 Sep; 17(10):1207-14. PubMed ID: 9771963
[TBL] [Abstract][Full Text] [Related]
15. Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway.
Jones DL; Thompson DA; Suh-Bürgmann E; Grace M; Münger K
Virology; 1999 Jun; 258(2):406-14. PubMed ID: 10366578
[TBL] [Abstract][Full Text] [Related]
16. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
Brokaw JL; Yee CL; Münger K
Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
[TBL] [Abstract][Full Text] [Related]
17. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
18. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.
Chien WM; Parker JN; Schmidt-Grimminger DC; Broker TR; Chow LT
Cell Growth Differ; 2000 Aug; 11(8):425-35. PubMed ID: 10965847
[TBL] [Abstract][Full Text] [Related]
19. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells.
Hiraiwa A; Kiyono T; Segawa K; Utsumi KR; Ohashi M; Ishibashi M
Virology; 1993 Jan; 192(1):102-11. PubMed ID: 8390746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
